|
CA2276532C
(en)
*
|
1997-01-06 |
2008-06-17 |
Cerus Corporation |
Frangible compounds for pathogen inactivation
|
|
CN1203900C
(zh)
|
1998-01-06 |
2005-06-01 |
塞鲁斯公司 |
用于淬灭生物材料中病原体灭活剂的方法
|
|
JP2002517435A
(ja)
|
1998-06-11 |
2002-06-18 |
シーラス コーポレイション |
動脈平滑筋細胞の増殖阻害のためのアルキル化化合物の使用
|
|
US7498156B2
(en)
|
1998-07-21 |
2009-03-03 |
Caridianbct Biotechnologies, Llc |
Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
|
|
US7049110B2
(en)
|
1998-07-21 |
2006-05-23 |
Gambro, Inc. |
Inactivation of West Nile virus and malaria using photosensitizers
|
|
US6403359B1
(en)
|
1998-09-25 |
2002-06-11 |
V. I. TECHNOLOGIES, Inc. |
Solid phase quenching systems
|
|
US6150109A
(en)
|
1999-01-25 |
2000-11-21 |
V. I. TECHNOLOGIES, Inc. |
Lipophilic quenching of viral inactivating agents
|
|
US7220747B2
(en)
|
1999-07-20 |
2007-05-22 |
Gambro, Inc. |
Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
|
|
US7094378B1
(en)
|
2000-06-15 |
2006-08-22 |
Gambro, Inc. |
Method and apparatus for inactivation of biological contaminants using photosensitizers
|
|
US20020042043A1
(en)
*
|
2000-05-31 |
2002-04-11 |
Adonis Stassinopoulos |
Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity
|
|
US9044523B2
(en)
|
2000-06-15 |
2015-06-02 |
Terumo Bct, Inc. |
Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
|
|
DE10051628B4
(de)
*
|
2000-10-18 |
2007-06-06 |
Fresenius Hemocare Beteiligungs Gmbh |
Einzelsträngiges Oligonukleotid und dessen Verwendung
|
|
CA2434256A1
(en)
*
|
2000-12-21 |
2003-07-31 |
David Cook |
Methods for inactivation of pathogens in biological materials
|
|
PT1592441E
(pt)
|
2003-02-06 |
2012-05-21 |
Aduro Biotech |
Listeria atenuada relativamente à entrada em células não patogénicas, vacinas compreendendo a listeria e métodos para sua utilização
|
|
WO2004084936A2
(en)
*
|
2003-02-06 |
2004-10-07 |
Cerus Corporation |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
|
US7695725B2
(en)
|
2003-02-06 |
2010-04-13 |
Aduro Biotech |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
|
US7842289B2
(en)
|
2003-12-24 |
2010-11-30 |
Aduro Biotech |
Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
|
|
CA2585621C
(en)
|
2004-10-29 |
2015-12-15 |
Cerus Corporation |
Improved quenching methods for red blood cell inactivation process
|
|
KR101896430B1
(ko)
|
2008-04-09 |
2018-09-10 |
세루스 코포레이션 |
적혈구 병원체 불활성화를 위한 개선된 퀀칭 방법
|
|
AU2014216178B2
(en)
|
2013-02-15 |
2018-06-28 |
KALA BIO, Inc. |
Therapeutic compounds and uses thereof
|
|
US9688688B2
(en)
|
2013-02-20 |
2017-06-27 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
|
|
EP2958895B1
(en)
|
2013-02-20 |
2020-08-19 |
Kala Pharmaceuticals, Inc. |
Therapeutic compounds and uses thereof
|
|
US9890173B2
(en)
|
2013-11-01 |
2018-02-13 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
CA2928658A1
(en)
|
2013-11-01 |
2015-05-07 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
CN104788373A
(zh)
*
|
2015-05-06 |
2015-07-22 |
武汉大学 |
化合物s-303盐酸盐的合成方法
|
|
EA201890149A1
(ru)
|
2015-06-26 |
2018-07-31 |
Сирус Корпорейшн |
Композиции криопреципитатов и способы их получения
|
|
CN104991033A
(zh)
*
|
2015-08-05 |
2015-10-21 |
上海海虹实业(集团)巢湖今辰药业有限公司 |
一种采用一测多评法测定川芎挥发油成分的方法
|
|
US10799533B2
(en)
|
2015-10-23 |
2020-10-13 |
Cerus Corporation |
Plasma compositions and methods of use thereof
|
|
CA3036340A1
(en)
|
2016-09-08 |
2018-03-15 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
AU2017324713B2
(en)
|
2016-09-08 |
2020-08-13 |
KALA BIO, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
CA3036065A1
(en)
|
2016-09-08 |
2018-03-15 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
AU2017382449B2
(en)
|
2016-12-23 |
2024-10-24 |
Cerus Corporation |
Systems and methods for testing and screening using compound bound substrates
|
|
BR112019018273A2
(pt)
|
2017-03-03 |
2020-07-14 |
Cerus Corporation |
kits e métodos para preparação de composições de plaquetas inativadas por patógenos
|
|
TWI821233B
(zh)
|
2017-12-29 |
2023-11-11 |
美商西勒斯股份有限公司 |
用於處理生物流體之方法、藉由該方法製備之病原體去活生物流體、及用於處理生物流體之系統
|
|
CA3143213A1
(en)
|
2019-06-22 |
2020-12-30 |
Cerus Corporation |
Biological fluid treatment systems
|
|
WO2020264421A1
(en)
|
2019-06-28 |
2020-12-30 |
Cerus Corporation |
System and methods for implementing a biological fluid treatment device
|